Targeted Liposomal Doxorubicin/Ceramides Combinations: The Importance to Assess the Nature of Drug Interaction Beyond Bulk Tumor Cells

AuthID
P-00W-KY0
Document Type
Article
Year published
2022
Published
in EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ISSN: 0939-6411
Volume: 172, Pages: 61-77 (17)
Indexing
Publication Identifiers
Pubmed: 35104605
Wos: WOS:000788094100006
Source Identifiers
ISSN: 0939-6411
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.